United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read General business news GTPL Hathway Q2 FY26 results: Can broadband growth offset cable TV slowdown and margin squeeze? GTPL Hathway posts 12% revenue growth in Q2 FY26 but sees profit fall 28% as margins shrink. Can broadband and OTT bundling fuel the next growth phase? bySrinathOctober 14, 2025